Sunday, March 20, 2011

DHA improves memory and cognitive function in older adults, study suggests

PharmaLive.com (9 November 2010) – a study published in the November edition of the disease of Alzheimer's dementia: the journal of the Alzheimer's Association suggests that taking Docosahexaenoic (ADH) may improve memory and learning among older adults with mild cognitive impairment. This is a new promising for the ageing of many Americans seeking options keep memory and support the overall cognitive health.

"Enhanced with Docosahexaenoic Acid Study memory" (MIDAS) is a double-blind, placebo-controlled, randomized study to assess the effects of ADH - principle-acid Omega 3 in the brain – to improve cognitive function in older adults with cognitive decline in healthy age-related standards.the ' study revealed that DHA taken six months improved memory and learning among adults in good health, aged sweet memory complaints.

"The results of this study are very encouraging for consumers concerned about maintaining memory." "We know that levels of DHA are associated with cognitive in healthy elderly and Alzheimer's disease patients decline and highest DHA levels will help to reduce the risk of Alzheimer's disease," said Duffy MacKay, N.D., Vice President, science & regulations, the Council for responsible nutrition (CRN). "Memory loss, dementia and Alzheimer's disease development are important health problems for older people. "More learn us about the valuable role that DHA plays supporting the functioning of the brain, the more options what American aging have declining cognitive management".

These results highlight the importance of early intervention of DHA.While that study MIDAS focused on a population of adults in good health with associated with age memory impairment, a study recently published in the journal of the American Medical Association (JAMA), conducted in a population that had previously been diagnosed with Alzheimer's disease, does not only DHA has provided significant cognitive function .the advantage ' JAMA study lead author also pointed out that their results were different DHA administered before the disease of participants grew.

"This study reinforces the principle that consumers will reap the benefit of the majority of their DHA - supplements and many supplements - when they are taken over time and before a health concern is imminent," continued Mr. MacKay."When it is included as part of a regime of proactive health includes a balanced diet, regular physical activity and systematic visits with a health care professional, dietary supplements are an important tool to help support many systems in the body, including memory and cognitive function."

MIDAS study was conducted on a total of 485 subjects aged 55 years and older with a subjective memory complaint satisfies the criteria relating to age cognitive decline (or "alteration of the memory associated with age") .sujets gived to random 900 mg/d of DHA algal orally or placebo for 24 weeks.

DHA is an omega-3 fatty acid and is available as Supplement alimentaire.De many Americans supplements each year round help manage the challenges associated with age.According to the survey on the consumption of the CNR on supplements, Americans aged 55 + taking supplements, 13% report that they are "memory" and 39 percent for "aging".

Editor's note: this article is not intended to provide medical advice, diagnosis or treatment.

Source of the story:

The story above is reproduced (with drafting adaptations by staff at PharmaLive.com) materials provided by the Council for responsible nutrition, via EurekAlert!, a service of AAAS.

Journal references:

Karin Yurko-Mauro, Deanna McCarthy, Dror Rom, Edward b. Nelson, Alan s. Ryan, Andrew Blackwell, Norman Salem Jr., Mary Stedman.Effects on cognition in linked to cognitive age Docosahexaenoic acid decreased .the Alzheimer's and dementia, 2010; 6 (6): 456 DOI: 10.1016/j.jalz.2010.01.013J.F.Quinn, r. Raman, r. g. Thomas, k. Yurko-Mauro, e. b. Nelson, v. Van Dyck, j. e. Galvin, j. Emond, c. r. Jack, Mr. Weiner, Shintoism l., P. s. Aisen.Docosahexaenoic acid supplementation and cognitive decline in Alzheimer's disease: A Randomized Trial.JAMA: Journal of the American Medical Association, 2010; 304 (17): 1903 DOI: 10.1001/jama.2010.1510

Note: If no author is given, the source is cited for this.


View the original article here

No comments:

Post a Comment